International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
Categories: GHG emissions baseline assessments, Action Plans for sustainable low carbon health systems
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Their vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere. To achieve this, IFPMA acts as a trusted partner, bringing their members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
Supporting the following commitments:
- Commitment 5: Deliver a baseline assessment of greenhouse gas emissions of the health system (including supply chains).
- Commitment 6: Develop an action plan or roadmap by a set date to develop a sustainable low carbon health system (including supply chains).
Country experience:
IFPMA does not have a presence in countries.
Links:
Site in English: www.ifpma.org